Evidence map›Paper›PMID 35920970›Full record

ReviewNeurochemical research2022

Ischemic Tolerance Induced by Glial Cells.

Schuichi Koizumi, Yuri Hirayama

Abstract readReview
In one paragraph

Review in Neurochemical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Schuichi KoizumiDepartment of Neuropharmacology, Yamanashi, Japan. skoizumi@yamanashi.ac.jp.ORCID http://orcid.org/0000-0001-6184-3106
Yuri HirayamaDepartment of Neuropharmacology, Yamanashi, Japan.

Funding

Japan Agency for Medical Research and Development 22gm1310008KAKENHI 18H05121, 19H04746, 20H05060, 20H05902 and 21H04786Mitsubishi Foundation Mitsubishi FoundationTakeda Science Foundation Takeda Science FoundationYamanashi GLIA Center Grant Yamanashi GLIA Center Grant
6 · The paper itself

Abstract

Ischemic tolerance is a phenomenon in which resistance to subsequent invasive ischemia is acquired by a preceding noninvasive ischemic application, and is observed in many organs, including the brain, the organ most vulnerable to ischemic insult. To date, much research has been conducted on cerebral ischemic tolerance as a cell-autonomous action of neurons. In this article, we review the essential roles of microglia and astrocytes in the acquisition of ischemic tolerance through neuron-non-autonomous mechanisms, where the two types of glial cells function in a concerted manner to induce ischemic tolerance.

Indexed as

Brain IschemiaIschemic PreconditioningAstrocytesHumansIschemiaMicrogliaAstrocytesIschemic toleranceMicrogliaP2X 7 receptor.Purinergic signals

Identifiers

PMID35920970
PMCPMC9463280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.